The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

D•••••••• I••

Life Sciences Tools & Servicesgroup grade Aon a schedule nowsponsor not established · possible relationship
Also written as: 2014; 21; 3; 3/21/2014; and D•••••••• I••; Equity; Equity and
See every lender's markFind rescue capital
More
Special situations PE firms

Nothing material in the last 200 days. No dated change on record yet.

Mark path, consensus per quarter end
Q2 2025: 100¢Q3 2025: 99¢Q4 2025: 101¢Q1 2026: 100¢Q2 2026: 100¢100¢ · 99¢ · 101¢ · 100¢ · 100¢Q2 2025 to Q2 2026
Where each lender marks it, 0 points apart
100¢Consensus: 100¢B•••••••• T•• C•••••• C••••: 100¢B•••••••• P•••••• C••••• F•••: 100¢B•••••••• D••••• L•••••• C••••: 100¢100¢
Principal held
at least $15.4M
sum of BDC pieces, a lower bound
Fair value
$15.3M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
4
4 on the latest quarter
Facilities
2
1 equity pieces beside them
Next maturity
Dec 18, 2029
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
0
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
LenderExposureCurrent markQoQ change
B•••••••• T•• C•••••• C••••$7.88M100¢0 pts
B•••••••• P•••••• C••••• F•••$7.2M100¢0 pts
B•••••••• D••••• L•••••• C••••$300K100¢0 pts
Every BDC piece · 7 positions across 4 lenderslargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
B•••••••• T•• C•••••• C••••term loan first lien
F•••• L••• T••• L••• Ref S•••(M) F•••• 3.00% S••••• 5.25% T•••• C••••• 8.89% M••••••• 12/2
$6.6M$6.5M
100c
SOFR+525 bp
B•••••••• P•••••• C••••• F•••term loan first lien
I••••••••• F•••• L••• T••• L••• Ref S•••(M) F•••• 3.00% S••••• 5.25% T•••• C••••• 8.89% M•
$6.0M$5.9M
100c
SOFR+525 bp
B•••••••• T•• C•••••• C••••delayed draw term loan first lien
F•••• L••• D•••••• D••• T••• L••• Ref S•••(M) F•••• 3.00% S••••• 5.25% T•••• C••••• 8.89%
$1.3M$1.3M
100c
SOFR+525 bp
B•••••••• P•••••• C••••• F•••delayed draw term loan first lien
I••••••••• F•••• L••• D•••••• D••• T••• L••• Ref S•••(M) F•••• 3.00% S••••• 5.25% T•••• C•
$1.2M$1.2M
100c
SOFR+525 bp
B•••••••• D••••• L•••••• C••••term loan first lien
I••••••••• F•••• L••• T••• L••• Ref S•••(M) F•••• 3.00% S••••• 5.25% T•••• C••••• 8.89% M•
$250,000$248,000
100c
SOFR+525 bp
View all 7 positionslargest principal first
BDCInstrumentPrincipalFair valueRate
B•••••••• D••••• L•••••• C••••delayed draw term loan first lien
I••••••••• F•••• L••• D•••••• D••• T••• L••• Ref S•••(M) F•••• 3.00% S••••• 5.25% T•••• C•
$50,000$49,600
100c
SOFR+525 bp
H••••••• C••••••• I•••preferred equity equity
P•••••••• Series C
Not disclosed$12,000
12c
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $12.8M100cSOFR+525 bpDec 20, 20293
first lien delayed draw term loan first lienat least $2.6M100cSOFR+525 bpDec 18, 20293
Equity pieces beside the debt: preferred equity ($12,000 fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20264$15.4M$15.2M100c0
Mar 31, 20264$15.4M$15.0M100c0
Dec 31, 20254$15.4M$15.3M102c0
Sep 30, 20254$16.1M$14.9M99c0
All 15 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20254$15.3M$14.8M100c0
Mar 31, 20254$16.1M$14.9M100c0
Dec 31, 20244$15.7M$15.1M100c0
Sep 30, 20241$0$0n/a0
Jun 30, 20241$0$0n/a0
Mar 31, 20241$0$0n/a0
Dec 31, 20231$0$0n/a0
Sep 30, 20231$0$0n/a0
Jun 30, 20231$0$0n/a0
Mar 31, 20231$0$0n/a0
Dec 31, 20221$0$0n/a0
What changed
Every change including routine ones
Identity
Group key
DNANEXUSderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 4 BDCsderived
Industry
Life Sciences Tools & Servicesreportedas one filer wrote it